Author:
Hou Chen,Jin Yingqi,Wu Hua,Li Pengyi,Liu Longyun,Zheng Kang,Wang Chuan
Abstract
Chlamydia is an obligate intracellular bacterium where most species are pathogenic and infectious, causing various infectious diseases and complications in humans and animals. Antibiotics are often recommended for the clinical treatment of chlamydial infections. However, extensive research has shown that antibiotics may not be sufficient to eliminate or inhibit infection entirely and have some potential risks, including antibiotic resistance. The impact of chlamydial infection and antibiotic misuse should not be underestimated in public health. This study explores the possibility of new therapeutic techniques, including a review of recent studies on preventing and suppressing chlamydial infection by non-antibiotic compounds.
Funder
Natural Science Foundation of Hunan Province
Subject
Microbiology (medical),Microbiology
Reference151 articles.
1. Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial;Abraham;Lancet. Infect. Dis,2019
2. No benefit of chlamydia screening in primary care?;Adamson;Lancet.,2018
3. Inhibitory effect of dietary phenolic compounds on Chlamydia. pneumoniae in cell cultures;Alvesalo;Biochem. Pharmacol,2006
4. Antibiotics, gut microbiota, and Alzheimer's disease;Angelucci;J. Neuroinflamm,2019
5. Chlamydia trachomatis evokes a relative anti-inflammatory response in a free Ca2+ dependent manner in human macrophages;Azenabor;Comp. Immunol. Microbiol. Infect. Dis,2010
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献